📰 6 sources covering this story

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine

First covered 2 days ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

The Japan Times1 hrs ago

Pattern hair loss affects an estimated 50 million men and 30 million women in the U.S., but there have been no new approved drugs since the late 1990s.

Trust?Read on The Japan Times ↗

CNBC17 hrs ago

Top Wall Street analysts suggest these 3 dividend stocks for consistent income

These three dividend stocks offer steady income in turbulent markets.

Trust?Read on CNBC ↗

Fortune1 days ago

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine

Pattern hair loss affects an estimated 50 million men and 30 million women in the US, but there have been no new approved drugs since the late 1990s.

Trust?Read on Fortune ↗

Reuters2 days ago

Wall St Week Ahead Jobs report, Broadcom results pose next hurdles for stock market rally

Wall St Week Ahead Jobs report, Broadcom results pose next hurdles for stock market rally Reuters

Trust?Read on Reuters ↗

Quartz2 days ago

Is Chewy (CHWY) a Buy as Wall Street Analysts Look Optimistic?

According to the average brokerage recommendation (ABR), one should invest in Chewy (CHWY). It is debatable whether this highly sought-after metric is effective

Trust?Read on Quartz ↗

NYT Business🏁 first to report2 days ago

What if the A.I. Stock Market Rally Is Just Getting Started?

Edward Yardeni, an upbeat strategist with an excellent track record in assessing the stock market, explains why he thinks the good times will continue for years.

Trust?Read on NYT Business ↗